Duration of Benefit for OnabotulinumtoxinA in Treatment of Chronic Migraine

NCT02037425 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

44

Enrollment

INDIV

Sponsor class

Conditions

Chronic Migraine

Interventions

DRUG: onabotulinumtoxinA

Sponsor

Cady, Roger, M.D.

Collaborators

[object Object]